Close

Analyst Ratings for Reneo Pharmaceuticals (RPHM)

RPHM Rating Summary

RPHM Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RPHM
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $6.56 (+274.9%) * Over Last 12-Mos
Rating Score: 1.3 / 10   Percentile Rank: 9%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/15/2023 H.C. Wainwright Mitchell Kapoor Downgrade Neutral
(Buy)
N/A
(N/A)
1.34
(1.75)
30.6% Details
12/15/2023 Leerink Partners Joseph P. Schwartz Downgrade Market Perform
(Outperform)
1.00
(15.00)
7.75
(1.75)
-77.42% Details